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Abstract Sister-chromatid separation is triggered by a speci¢c
proteolytic cleavage of chromosomal cohesins catalyzed by the
endopeptidase separase. Prior to anaphase, separase is inhibited
independently by a⁄nity binding to securin and by speci¢c in-
hibitory phosphorylation. Here we show that separase itself is
also subjected to proteolytic cleavages at three adjacent sites.
The cleavages are auto-catalyzed and occur speci¢cally at ana-
phase coincident with separase activation. The cleaved frag-
ments remain associated with each other and are catalytically
active. Mapping of the cleavage sites reveals that all three sites
are conserved in vertebrates underlining a signi¢cant function
for this regulation. # 2002 Published by Elsevier Science B.V.
on behalf of the Federation of European Biochemical Societies.
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1. Introduction
The partition of the replicated genetic material occurs at the
metaphase to anaphase transition of the cell division cycle [1].
At this transition, sister chromatids aligned on the metaphase
plate separate simultaneously from each other and migrate to
opposite poles. Although the cytological description of this
transition was ¢rst documented over a century ago, the mo-
lecular mechanisms that choreograph these chromosome
movements are being elucidated only recently. Sister chroma-
tids are physically paired with each other immediately after
their replication [2,3]. By doing so, cells avoid having to re-
identify sisters later to ensure equal partitioning in mitosis.
The establishment and maintenance of cohesion requires a
¢ve-subunit cohesin complex [4^6]. The key protein that reg-
ulates the dissolution is a cysteine protease known as separase
[7]. Activated at anaphase, separase cleaves the cohesin sub-
unit SCC1/MCD1 at two speci¢c sites, a process both neces-
sary and su⁄cient to trigger the separation of sister chroma-
tids [8].
The regulation of separase activity is apparently critical for
the temporal control of sister-chromatid separation. Separase
is inhibited by at least two independent mechanisms prior to
anaphase. The ¢rst inhibitory mechanism is mediated by a
small protein inhibitor called securin, which forms a protein
complex with separase [9^12]. The second mechanism is
achieved by an inhibitory phosphorylation on separase, which
appears to be regulated, directly or indirectly, by the CDC2/
cyclin B kinase [13]. In this report, we describe a third mech-
anism that modi¢es separase via a proteolytic cleavage event
on separase itself.
2. Materials and methods
2.1. Constructs and reagents
Various separase mutants were created by site-directed mutagenesis
using either the QuickChange kit (Stratagene) or the GeneEditor sys-
tem (Promega). All constructs were con¢rmed by DNA sequencing
for the presence of the introduced mutations and for the absence of
unintended changes. The protease-inactive separase-CS mutant was
described previously [13]. The separase-2RA replaces R1486 and
R1506 with alanines. The separase-3RA replaces R1486, R1506, and
R1535 with alanines. The separase-TEV2 replaces 1504-ILRGSDG-
EDSASG-1516 with two TEV cleavage sites, NLYFQGENLYFQ, in
addition to the R1486A and R1535A mutations. All constructs were
cloned into a pCS2-based expression plasmid designed for amino-ter-
minal fusion with HA2-, HA3 or myc6-tags. Anti-HA (3F10) and anti-
c-myc (9E10) were obtained from Roche. The preparation of a⁄nity-
puri¢ed anti-separase antibody, recombinant securin, and active sep-
arase has been described elsewhere [10,13].
2.2. Cell culture, transfection, and synchronization
Both HeLa S3 and 293T cells were maintained in Dulbecco’s modi-
¢ed Eagle’s medium (Invitrogen) supplemented with 10% fetal bovine
serum. 293T cells were transiently transfected with a calcium phos-
phate-based method. Both cell lines were synchronized by either a
double-thymidine or a thymidine-nocodazole arrest protocol [15].
2.3. In vitro separase activity assay and size exclusion chromatography
of active separase
The activity assay was performed as described previously [13] ex-
cept that for Fig. 4 the immunocomplex on agarose beads was used
directly in the cleavage reaction. For each reaction, 5 Wl beads were
incubated at 37‡C with 1 Wl in vitro translated and radioactively
labeled cohesinSCC1=MCD1 in 4 Wl cleavage bu¡er (30 mM HEPES/
KOH pH 7.7, 30% glycerol, 25 mM NaF, 25 mM KCl, 5 mM MgCl2,
1.5 mM ATP, 1 mM EGTA). For size exclusion chromatography of
active separase, ZZ-TEV4-separase was co-expressed with securin,
activated in Xenopus extract, and re-isolated on IgG-Sepharose as
described [13]. After elution with TEV protease, separase was diluted
1:1 in 30 mM HEPES-KOH pH 7.8, 2 mM DTT, 5 mM EDTA,
5 mM EGTA, 1 M NaCl and separated on a Superose 6 column
(PC 3.2/30, Amersham) in the same bu¡er. Separase eluted with an
apparent molecular weight of 600 kDa as judged by anti-separase
immunoblot. For the activity assay, the Superose 6 fractions were
dialyzed against cleavage bu¡er in the presence of 35S-labeled
cohesinSCC1=MCD1 for 2 h at 37‡C.
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2.4. Mapping of the cleavage sites
Myc6-separase was expressed in 293T cells and arrested at meta-
phase [13]. To release cells into anaphase, nocodazole was washed
away and the culture was returned to the incubator for an additional
2 h. Cells were harvested and lysed with ice-cold lysis bu¡er (150 mM
NaCl, 20 mM Tris pH 8.0, 10% glycerol, 2 mM MgCl2, 0.1 mM
EDTA, 0.5% NP-40) supplemented with 1 mM L-microcystin. Next,
an S100 was prepared and separase was a⁄nity-puri¢ed using anti-c-
myc agarose beads (Roche). The beads were washed twice with lysis
bu¡er and twice with lysis bu¡er in the presence of 500 mM NaCl and
1% NP-40. Separase was eluted at 37‡C for 30 min by two incubations
with 2 mg/ml myc peptide (Roche) dissolved in lysis bu¡er. Eluted
proteins were separated by SDS^PAGE and detected by silver stain-
ing. The corresponding bands were subjected to in-gel digestion and
subsequently analyzed by nanoelectrospray using a quadrupole-time-
of-£ight mass spectrometer. Alternatively, the proteins were trans-
ferred onto a Sequi-Blot PVDF membrane (Bio-Rad) and detected
by Coomassie staining. The corresponding band was cut out and
automated Edman degradation was performed by ProSeq (Boxford,
MA, USA).
3. Results and discussion
We ¢rst noticed the cleavage of separase when we were
analyzing the cell cycle regulation of separase in synchronized
HeLa S3 cultures. Separase from cultures at di¡erent stages of
the cell cycle were enriched by immunoprecipitation followed
by anti-separase immunoblot. As a temporal control, the same
blot was also analyzed for the levels of securin. Excess
amounts of anti-separase beads were used in the immunopre-
cipitation step to ensure quantitative capture of all separase in
the lysate. This was con¢rmed by the absence of separase in
the supernatants (data not shown). As shown in Fig. 1, the
level of full-length separase decreases upon entry into the
anaphase concomitantly with degradation of securin. At the
same time, two bands with molecular weights of approxi-
mately 170 kDa and 60 kDa were detected indicating that
separase was being cleaved. Since both fragments were de-
tected by the antibody, we expected the cleavage site to reside
within the peptide used to raise the antibody (Ser1305 to
Thr1573 of the 2120 residues long separase). The identity of
the 170 kDa band was con¢rmed by detection with an anti-
body raised against the N-terminal 15 amino acids of separase
[13]. The anaphase speci¢c cleavage is unlikely an artifact of
the nocodazole arrest since most separase remained intact
when the drug was not removed, even after incubation for
12 h. Furthermore, cleavage was also observed when a culture
went through mitosis in the absence of nocodazole upon re-
lease from a double-thymidine arrest (data not shown). Con-
sistent with this observation, human separase is cleaved in
Xenopus extracts arrested at anaphase [13,14].
To gain further insight into this proteolytic event, we next
searched for the protease that is responsible for this cleavage.
Separase itself is an endopeptidase. We therefore examined
whether the cleavage is self-imposed. By changing the catalytic
residue cysteine to a serine, we generated a protease-inactive
mutant, separase-CS [8,13]. A HA2-tag was fused to the ami-
no-terminus of separase-CS to facilitate detection. When this
mutant was introduced into 293T cells, the cleavage was
largely blocked (Fig. 2A, lane 2). This is in a striking contrast
with the wild-type separase (lane 1), of which about 50% was
detected in the cleaved form. The residual amount of cleaved
separase-CS was presumably due to the activity of the endog-
enous separase (see below). Therefore, we conclude that the
anaphase speci¢c cleavage requires the proteolytic activity of
separase itself. This is consistent with a simple model that
separase cleavage is auto-catalyzed, which is further supported
by the mapping of the cleavage sites (see below). We noticed
that unlike with endogenous separase in HeLa S3 cells, we
rarely detected more than 50% cleavage when separase was
transfected in 293T cells. Over-expression and inferior syn-
chronization in the latter case are the likely explanation for
this di¡erence.
To characterize the auto-proteolytic reaction, we analyzed
whether it occurs via an inter-molecule mechanism. This
would predict that wild-type separase is able to cleave pro-
tease-inactive separase-CS. To test this model, HA3-separase-
CS and myc6-separase-WT were co-transfected together with
securin into 293T. Lysates from anaphase cells were analyzed
by immunoblot with anti-HA. As shown in Fig. 2A, HA2-
separase-CS was cleaved when co-expressed with the myc6-
separase-WT (lane 5) but remained intact when co-expressed
with myc6-separase-CS (lane 3). This result suggests that the
cleavage can be catalyzed via an inter-molecule mechanism. It
also explains the small amount of cleavage of separase-CS
when introduced into 293T cells as these cells also express
endogenous separase (Fig. 2A, lane 2). This experiment, how-
ever, does not address whether intra-molecule reaction also
contributes to the self-cleavage.
Does the cleavage of separase result in dissociation of the
fragments? To clarify this issue, we generated active separase
by incubation of a separase^securin complex in a Xenopus
extract to degrade securin. Separase was re-puri¢ed from the
extract via an N-terminal tag and eluted from the a⁄nity
matrix [13]. The eluate was then further puri¢ed by gel ¢ltra-
tion in 1 M NaCl. As shown in Fig. 2C, the N- and C-termi-
nal separase fragments co-migrated perfectly despite their
Fig. 1. Cell cycle regulation of separase cleavage in HeLa S3 cells.
The dynamics of endogenous separase were analyzed by immuno-
precipitation and anti-separase immunoblot. The hollow arrow indi-
cates a cross-reacting band. In addition to the 220 kDa full-length
separase, a 170 kDa and a 60 kDa fragment were detected as N-ter-
minal and C-terminal halves of separase, respectively. As a temporal
control, the levels of securin were also determined by immunoblot
with anti-securin.
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large di¡erences in size (upper panel). Furthermore, the re-
spective fractions exhibited separase activity as judged by a
standard cohesinSCC1=MCD1 cleavage assay (lower panel) [13].
The fact that the separase cleavage fragments co-puri¢ed by
a⁄nity and size exclusion chromatography in the presence of
high salt concentrations demonstrates that, following auto-
cleavage, the separase fragments stay bound to each other
in a stable complex. No full-length separase was detectable
in the corresponding fractions, which allows us to conclude
that the interaction of the fragments is not bridged by un-
cleaved separase.
We wanted to map the cleavage site of separase. To this
end, we expressed myc6-separase-WT in 293T cells. Co-ex-
pression with securin was performed since expression of sep-
arase alone leads to a reduction in the levels of both expres-
sion and self-cleavage activity (Fig. 3A, lane 1). This
observation is consistent with the notion that securin also
plays a positive role in regulating separase stability and activ-
ity in addition to its inhibitory function [16]. After release of
the transfected cells from a nocodazole arrest, separase was
a⁄nity-puri¢ed from a crude extract using anti-c-myc beads.
After extensive washing with up to 0.5 M NaCl and 1% NP-
40, bound proteins were eluted by incubation with myc pep-
tide. As expected, the C-terminal 60 kDa fragment of separase
co-eluted with the N-terminal myc6-tagged 170 kDa fragment.
The C-terminal fragment was analyzed by Edman degrada-
tions. The sequence obtained (GSDGEDSASGG) matches
perfectly with amino acids 1507^1517 of separase. Intrigu-
ingly, this sequence is preceded immediately with E-I-L-R, a
motif that has been reported to be the consensus site (E-X-X-
R) for separase [8]. Therefore, the cleavage was mapped after
Arg1506. In parallel, the C-terminal fragment was also ana-
lyzed by mass spectrometry. Eleven peptides were identi¢ed
(data not shown). Consistently, all peptides reside C-terminal
of Arg1506 and the most N-terminal peptide identi¢ed starts
at T1519, 12 residues away from the mapped site.
In an attempt to generate a non-cleavable mutant, we
changed Arg1506 to Ala. As shown in Fig. 3B, lane 3, sepa-
rase-R1506A was still cleaved indicating the existence of a
second cleavage site. Using separase-R1506A we tried again
automated Edman degradation to map this site. However,
among 11 cycles, only four amino acids (xIxxEELxxxx)
were unambiguously identi¢ed. The mapped sequence was
consistent with a cleavage after Arg1486, which is again
part of a consensus site (E-I-M-R). The ambiguity in this
mapping experiment could result from a third site that was
Fig. 2. Characterization of separase cleavage. A: Crude lysates from anaphase 293T cells co-transfected with active HA2-separase-WT (lane 1)
and proteolytic inactive HA2-separase-CS (lane 2), HA2-separase-CS and myc6-separase-CS (lane 3), HA2-separase-WT and myc6-separase-CS
(lane 4), and HA2-separase-CS and myc6-separase-WT (lane 5) were probed with anti-HA to detect full-length separase and its N-terminal
cleavage fragment. B: The N- and C-terminal fragments of cleaved separase remain stably associated. N-terminally tagged, active separase was
a⁄nity-puri¢ed from Xenopus extract and further separated by size exclusion chromatography. Resulting fractions were probed for separase
fragments and cohesinSCC1=MCD1 cleavage activity.
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cleaved at a comparable e⁄ciency as the site at R1486. This
was con¢rmed by that fact that mutations at both R1506 and
R1486 still fail to block the cleavage of separase (Fig. 3B, lane
4). A survey of the nearby sequence indeed revealed another
potential site at Arg1535 (E-L-L-R). Only when all three ar-
ginines were mutated (separase-3RA) was separase cleavage
almost completely blocked (Fig. 3B, lane 5). Still, several re-
maining faint bands suggest the existence of yet more cryptic
sites. The fact that all three major cleavage sites bear the
consensus recognition motif of separase is consistent with
the notion that the cleavage is catalyzed by separase directly.
Remarkably, in all three cleavage sites of human separase and
two reported cleavage sites on human cohesinSCC1=MCD1 [17],
there is at least one hydrophobic residue between the con-
served E and R (Fig. 3C).
To investigate whether the self-cleavage plays any role in
regulating chromatid separation, we ¢rst compared the activ-
ity of separase in its intact form with that in the cleaved form.
We modi¢ed the separase cleavage sites by changing both
Arg1486 and Arg1535 to Ala and replacing the sequences
including Arg1506 with two TEV protease cleavage sites.
The Arg1506 site was replaced with TEV cleavage sequence
because this site seems to be the primary cleavage site in vivo
based on the mapping results described above. The resulting
separase-2TEV behaved similarly to separase-3RA when
Fig. 3. Mapping of the cleavage sites of separase. A: Myc6-separase
was co-transfected with either HA2-securin (lane 2) or pCS2-HA2
vector (lane 1). The expression levels were determined by immuno-
blot with anti-c-myc. The activity of separase was indicated by the
amount of the self-cleavage products. Immunoblot with anti-HA
was performed to con¢rm the expression of transfected securin.
B: HA3-tagged separase-WT (lane 1), -CS (lane 2), -R1506A (lane
3), -2RA (lane 4), or -3RA (lane 5) were prepared from transfected
293T cells in anaphase. The full-length and cleaved N-terminal frag-
ments were detected by anti-HA. C: Sequences comparison of
known vertebrate separase cleavage sites. The invariable E and R
are in bold.
Fig. 4. Separase self-cleavage sites are conserved in vertebrates but self-cleavage has no e¡ect on separase activity in vitro. A: Separase cleavage
can be mimicked by cleavage of separase-TEV2 with TEV protease. HA3-separase-TEV2 was immunopuri¢ed on anti-HA matrix and incubated
with recombinant TEV protease (lane 2) or TEV bu¡er only (lane 1) for 30 min at room temperature. The extent of cleavage was examined by
immunoblot with anti-HA. B: Comparison of the kinetics of cohesinSCC1=MCD1 cleavage by full-length and cleaved separase. C: Alignment of
human, mouse, and Xenopus separase sequences including the cleavage sites. The human sequence was taken from the cDNA clone KIAA0165.
The mouse sequence is derived by combining sequences of EST clones. The Xenopus separase sequence was derived from a PCR clone ampli¢ed
from an egg cDNA library. The numbers on the left side are the positions of the corresponding amino acids. No number is provided for the
mouse separase since the full-length sequence is not available. Conserved residues among all three species are shaded in black. The cleavage
sites are indicated by the arrows and the conserved E-X-X-R motifs are underlined.
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transfected in 293T cells (Fig. 3B, lane 5). As before, we
puri¢ed separase-TEV2 from transfected, nocodazole-arrested
293T cells and securin was removed in Xenopus extract. The
resulting separase preparation was split. Half was incubated
with recombinant TEV protease to generate cleaved separase
(Fig. 4A, lane 2). The other half was mock-incubated with
bu¡er only to leave separase intact (Fig. 4A, lane 1). Finally,
the activities of both preparations were compared with each
other in the cohesinSCC1=MCD1 cleavage assay. As shown in
Fig. 4B, the proteolytic activity of cleaved separase is virtually
identical to that of full-length separase. The same result was
obtained when we compared cleaved separase-WT with intact
separase-3RA in a similar experiment (data not shown). These
results demonstrated that ^ at least in vitro ^ cleavage has no
e¡ect on separase activity.
If the limited proteolysis of separase had no function at all,
one would not expect the cleavage sites to be conserved, es-
pecially as separase of di¡erent species is highly divergent
outside the catalytic C-terminal domain. We have cloned the
gene for Xenopus separase and determined the sequence
around its putative cleavage sites. Sequence comparison with
the existing sequences of human and mouse separase revealed
that all three cleavage sites are conserved in an otherwise
largely diverse region (Fig. 4C). This evolutionary conserva-
tion in vertebrates indicates that these sites and the cleavage
events themselves are important. The above results do not rule
out the possibility that other aspects of separase function that
are not probed by our in vitro activity assay are a¡ected by
the self-cleavage. For example, cleavage could result in a
change of the sub-cellular localization of separase. Alterna-
tively, cleavage might result in destabilization of separase sim-
ilar to the situation with Saccharomyces cerevisiae cohesin
SCC1/MCD1 [18]. Further studies are necessary to reveal
the speci¢c cellular function of the separase auto-cleavage.
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